Copertina

Investigation of Anti‐IgG Antibody Responses to the 17‐kDa Outer Membrane Protein of Rickettsia japonica in Individuals From a High‐Risk Area for Japanese Spotted Fever

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Makoto Kondo, Koji Habe, Keiichi Yamanaka
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Experimental Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Overlooked Brill‐Zinsser Disease Presenting Like Japanese Spotted Fever: A Diagnostic Challenge
di: Makoto Kondo, et al.
Pubblicazione: (2025)

Estimating Japanese Spotted Fever Risk: Numerical Differences Between Field‐Dwelling and Human‐Biting Tick Species
di: Makoto Kondo, et al.
Pubblicazione: (2025)

Recurrent Cutaneous Mycobacterium chelonae Infection With an IgM ‐Predominant Antibody Response in DiGeorge Syndrome
di: Makoto Kondo, et al.
Pubblicazione: (2026)

A case of Japanese spotted fever probably transmitted by a tick bite caused by Haemaphysalis cornigera
di: Makoto Kondo, et al.
Pubblicazione: (2024)

A case of Stevens–Johnson syndrome after influenza a virus infection
di: Chiaki Sakashita, et al.
Pubblicazione: (2024)

Multiple Ulcers Associated With Deep Vein Thrombosis Secondary to Herpes Zoster Infection of the Lower Limb
di: Makoto Kondo, et al.
Pubblicazione: (2025)

Early Tick Species Identification Using Eschar‐Based PCR to Guide Presymptomatic Risk Assessment in Tick‐Borne Diseases
di: Makoto Kondo, et al.
Pubblicazione: (2026)

Japanese Spotted Fever With Marked Serological Cross‐Reactivity to Rickettsia typhi Confirmed by Sequence‐Based Molecular Analysis: A Case Report
di: Natsumi Fushida, et al.
Pubblicazione: (2026)

Integrated management with topical and injectable 200 kDa hyaluronic acid for erythematous rosacea
di: Ilaria Proietti, et al.
Pubblicazione: (2024)

A Case of IgM Pemphigoid Suggesting Possible Transition to IgG Mucous Membrane Pemphigoid
di: Nobushige Kohri, et al.
Pubblicazione: (2026)

Dermoscopic image of the hairs in a very early lesion of tinea capitis caused by Trichophyton rubrum
di: Makoto Kondo, et al.
Pubblicazione: (2024)

Linear IgA/IgG bullous dermatosis presenting with refractory oral and esophageal erosions: A case report
di: Risa Kim, et al.
Pubblicazione: (2024)

A Case of DPP ‐4 Inhibitor‐Associated Bullous Pemphigoid With Anti‐ LAD ‐1 IgG Antibodies Arising From a Post‐Traumatic Scar
di: Momoko Sasamoto, et al.
Pubblicazione: (2025)

Sunflower Seed–Induced Anaphylaxis With Immunoglobulin E Reactivity to 2S Albumins and Novel 60 kDa Antigen Identified by Immunoblot Analysis
di: Ayaka Aoki, et al.
Pubblicazione: (2026)

A case of IgG4‐related disease presenting as skin tumors in the bilateral cheeks
di: Taro Akatsuka, et al.
Pubblicazione: (2024)

Remission of intercellular IgG/IgA dermatosis after treatment for cervical cancer
di: Shohei Kitayama, et al.
Pubblicazione: (2024)

Spotted Fever After Safari and the Value of an Eschar Swab
di: Aoife Boyle, et al.
Pubblicazione: (2025)

IgG Signalling Involves in Skin Inflammation of Atopic Dermatitis
di: Jing Xu, et al.
Pubblicazione: (2025)

Neonatal lupus erythematosus with histopathological presentation of interstitial granulomatous dermatitis
di: Yuki Mizutani, et al.
Pubblicazione: (2024)

Differential Profiles of IL ‐31‐ and IL ‐5/ IL ‐13‐Producing Cells Among Helper T Cells, With Subtle IL ‐31 Expression in Innate Lymphoid Cells
di: Mai Nishimura, et al.
Pubblicazione: (2025)

GAVE in Systemic Sclerosis: A Japanese Cohort Study Highlighting Links to Diffuse Cutaneous Subtype and Anti‐ RNAPIII Antibodies
di: Takashi Matsushita, et al.
Pubblicazione: (2025)

Low pH condition impairs BP‐IgG binding to the basement membrane zone
di: Dongjun Im, et al.
Pubblicazione: (2024)

Anti‐Ki/ SL Antibody‐Positive Deep Morphea Patient Also Positive for Anti‐ PL ‐12 and Anti‐Ro60 Antibodies
di: Ikumi Hattori, et al.
Pubblicazione: (2025)

The Secretome of Bullous Pemphigoid IgG ‐Treated Keratinocytes Induces a Pro‐Inflammatory Eosinophil Response
di: Adrian P. Mansini, et al.
Pubblicazione: (2026)

Lymphoplasmacytic Plaque on the Dorsum of the Foot: Rapid Response to Potent Topical Corticosteroid
di: Yukako Suga, et al.
Pubblicazione: (2026)

Rapid induction of allergen‐blocking IgG in dogs vaccinated with plant‐based, Der f 2‐expressing bioparticles
di: Thierry Olivry, et al.
Pubblicazione: (2024)

Clinical Efficacy and Safety of Intramuscular Injections of Autologous Total IgG in Patients With Chronic Spontaneous Urticaria: An Open‐Label Prospective Pilot Trial
di: Young‐Min Ye, et al.
Pubblicazione: (2026)

Adult‐Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome on the Basis of Selective IgA Deficiency
di: Seda Altiner, et al.
Pubblicazione: (2024)

A Case of Anti‐ SAE Antibody‐Positive Dermatomyositis Coexisting With Sjögren's Disease
di: Ayako Fukumoto, et al.
Pubblicazione: (2026)

Acrokeratosis Paraneoplastica (Bazex Syndrome)‐Like Dermatomyositis With Anti‐ PM /Scl Antibodies
di: Mayuko Matsuda, et al.
Pubblicazione: (2025)

Anti‐ p200 Pemphigoid in an Infant Clinically Mimicking Linear IgA Disease
di: Elek A. Wellman, et al.
Pubblicazione: (2026)

The role of interleukin‐36 in health and disease states
di: Kazumitsu Sugiura, et al.
Pubblicazione: (2024)

Distinct Nailfold Videocapillaroscopy Findings in Patients With Anti‐Aminoacyl‐ tRNA Synthetase Antibodies
di: Naoki Mugii, et al.
Pubblicazione: (2025)

Cutaneous Lesions and Lung Squamous Cell Carcinoma Both Successfully Controlled With Chemoradiotherapy in a Patient With Cancer‐Associated Clinically Amyopathic Dermatomyositis With Anti‐Nuclear Matrix Protein 2 Antibodies
di: Arisu Sakai, et al.
Pubblicazione: (2026)

Refractory Psoriatic Lesions in Japanese Patients With Biologics
di: Takayo Ando, et al.
Pubblicazione: (2026)

Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021
di: Toshihiko Hoashi, et al.
Pubblicazione: (2024)

Correction to “Spesolimab: A Comprehensive Review on the Anti‐ IL ‐36 Receptor Antibody in Dermatology”
Pubblicazione: (2025)

Immune‐Mediated Necrotizing Myopathy Overlapping With Anti‐ RuvBL1 /2 Antibody‐Positive Systemic Sclerosis
di: Rikako Isobe, et al.
Pubblicazione: (2025)

Prognostic Biomarkers for Anti‐ PD ‐1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma
di: Marek Pásek, et al.
Pubblicazione: (2025)

Effectiveness of Anti‐ IL ‐13 Antibodies on Head and Neck Lesions in Atopic Dermatitis: 48‐Week Outcomes by Lebrikizumab and Tralokinumab
di: Mizuki Shiba, et al.
Pubblicazione: (2026)